Free Trial

Enzo Biochem (ENZ) SEC Filings & 10K Form

Enzo Biochem logo
$0.66 -0.01 (-1.35%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Enzo Biochem SEC Filings

DateFilerForm TypeView
01/17/2025
3:44 PM
COUCHMAN JONATHAN (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:44 PM
Enzo Biochem (Issuer)
PULLY STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:44 PM
Enzo Biochem (Issuer)
Radoff Bradley Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:44 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:32 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:16 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:15 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/02/2024
3:15 PM
COUCHMAN JONATHAN (Reporting)
Enzo Biochem (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2024
12:02 PM
Enzo Biochem (Filer)
Form ARS
11/27/2024
3:15 PM
Enzo Biochem (Filer)
Form DEF 14A
10/29/2024
7:02 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
4:04 PM
Enzo Biochem (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/24/2024
4:19 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
4:22 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
4:23 PM
Eckert Patricia (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
6:50 PM
Cannon Kara (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:13 PM
Enzo Biochem (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/24/2024
3:44 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:46 PM
Cannon Kara (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:31 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:25 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/27/2024
6:22 PM
Cannon Kara (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
9:23 AM
1 MAIN CAPITAL MANAGEMENT, LLC (Filed by)
Enzo Biochem (Subject)
Form SC 13G/A
02/13/2024
8:35 AM
Enzo Biochem (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/02/2024
8:00 PM
Enzo Biochem (Issuer)
Radoff Bradley Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:01 PM
Enzo Biochem (Issuer)
TAGLIAFERRI MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:02 PM
Enzo Biochem (Issuer)
PULLY STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
7:33 AM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ENZ) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners